Role of farnesoid X receptor in cholestasis

被引:40
|
作者
Yuan, Zhi Qing [1 ]
Li, Ke Wei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, 160 Pujian Rd, Shanghai 200127, Peoples R China
关键词
bile acid; cholestasis; enterohepatic circulation; farnesoid X receptor; hepatobiliary transport; ORGANIC SOLUTE TRANSPORTER; SALT EXPORT PUMP; BILE-ACID HOMEOSTASIS; CANALICULAR ABC TRANSPORTERS; ANIT-INDUCED HEPATOTOXITY; FXR-MEDIATED REGULATION; ALPHA-OST-BETA; NF-KAPPA-B; NUCLEAR RECEPTOR; DOWN-REGULATION;
D O I
10.1111/1751-2980.12378
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The nuclear receptor farnesoid X receptor (FXR) plays an important role in physiological bile acid synthesis, secretion and transport. Defects of FXR regulation in these processes can cause cholestasis and subsequent pathological changes. FXR regulates the synthesis and uptake of bile acid via enzymes. It also increases bile acid solubility and elimination by promoting conjugation reactions and exports pump expression in cholestasis. The changes in bile acid transporters are involved in cholestasis, which can result from the mutations of transporter genes or acquired dysfunction of transport systems, such as inflammation-induced intrahepatic cholestasis. The modulation function of FXR in extrahepatic cholestasis is not identical to that in intrahepatic cholestasis, but the discrepancy may be reduced over time. In extrahepatic cholestasis, increasing biliary pressure can induce bile duct proliferation and bile infarcts, but the absence of FXR may ameliorate them. This review provides an update on the function of FXR in the regulation of bile acid metabolism, its role in the pathophysiological process of cholestasis and the therapeutic use of FXR agonists.
引用
收藏
页码:501 / 509
页数:9
相关论文
共 50 条
  • [31] Methylation Status of Farnesoid X Receptor and Pregnane X Receptor Gene Promoters Modulates Bile Acid Profile in Patients with Intrahepatic Cholestasis of Pregnancy
    Cabrerizo, Romina
    Castano, Gustavo O.
    Burgueno, Adriana L.
    Fernandez Gianotti, Tomas
    Pirola, Carlos J.
    Sookoian, Silvia
    HEPATOLOGY, 2012, 56 : 548A - 548A
  • [32] Role of farnesoid X receptor and bile acids in alcoholic liver disease
    Sharon Manley
    Wenxing Ding
    ActaPharmaceuticaSinicaB, 2015, 5 (02) : 158 - 167
  • [33] The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
    Sun, Lulu
    Cai, Jie
    Gonzalez, Frank J.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2021, 18 (05) : 335 - 347
  • [34] Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation
    Fujino, Tomofumi
    Takeuchi, Airi
    Maruko-Ohtake, Akiko
    Ohtake, Yosuke
    Satoh, Junichi
    Kobayashi, Tomonori
    Tanaka, Toshiaki
    Ito, Haruka
    Sakamaki, Ryosuke
    Kashimura, Ryo
    Ando, Ken
    Nishimaki-Mogami, Tomoko
    Ohkubo, Yasuhito
    Kitamura, Naomi
    Sato, Ryuichiro
    Kikugawa, Kiyomi
    Hayakawa, Makio
    JOURNAL OF BIOCHEMISTRY, 2012, 152 (06): : 577 - 586
  • [35] The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
    Lulu Sun
    Jie Cai
    Frank J. Gonzalez
    Nature Reviews Gastroenterology & Hepatology, 2021, 18 : 335 - 347
  • [36] Discovery of farnesoid X receptor and its role in bile acid metabolism
    Chiang, John Y. L.
    Ferrell, Jessica M.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2022, 548
  • [37] Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development
    Takahashi, Shogo
    Tanaka, Naoki
    Fukami, Tatsuki
    Xie, Cen
    Yagai, Tomoki
    Kim, Donghwan
    Velenosi, Thomas J.
    Yan, Tingting
    Krausz, Kristopher W.
    Levi, Moshe
    Gonzalez, Frank J.
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (12) : 1567 - 1582
  • [38] Role of farnesoid X receptor and bile acids in alcoholic liver disease
    Manley, Sharon
    Ding, Wenxing
    ACTA PHARMACEUTICA SINICA B, 2015, 5 (02) : 158 - 167
  • [39] ROLE OF FARNESOID X RECEPTOR AGONISTS IN THE IN VIVO AND IN VITRO EXPRESSION OF APOLIPOPROTEIN(a)
    Chennamsetty, I.
    Kostner, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 60 - 60
  • [40] Liver X receptor and farnesoid X receptor as therapeutic targets
    Rader, Daniel J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (11): : 15N - 19N